Evidence map›Paper›PMID 38571511›Full record

ArticlemicroPublication biology2024

Quantifying Morphology of a Differentiating Neuroblastoma Cell Line.

Jillian Fang, Whitney Kuwamoto, Geanna Miranda, Vanishree Rajagopalan, Tamira Elul

Open access · greenAbstract read
In one paragraph

Article in microPublication biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jillian FangFoundational Biomedical Sciences Department, College of Osteopathic Medicine, Touro University California, Vallejo, California, USA.
Whitney KuwamotoFoundational Biomedical Sciences Department, College of Osteopathic Medicine, Touro University California, Vallejo, California, USA.
Geanna MirandaFoundational Biomedical Sciences Department, College of Osteopathic Medicine, Touro University California, Vallejo, California, USA.
Vanishree RajagopalanBiological and Pharmaceutical Sciences Department, College of Pharmacy, Touro University California, Vallejo, California, USA.
Tamira ElulFoundational Biomedical Sciences Department, College of Osteopathic Medicine, Touro University California, Vallejo, California, USA.
Touro University California · US

Funding

Cannabinoid Signaling Interactions During Axon Development in situR15DA058203 · NIDA · TOURO UNIVERSITY OF CALIFORNIA · PI ELUL, TAMIRA · 2023 to 2023
$364k
NIDA NIH HHS R15 DA058203
6 · The paper itself

Abstract

SH-SY5Y neuroblastoma cells are a subclone cell line of SK-N-SH cells derived from neural crest that were originally taken from human bone marrow during a biopsy. Research has shown that these cells can be cultured in vitro to differentiate into mature, neuronal phenotypes such as dopaminergic neurons. Here, we added to these discoveries by establishing a quantitative profile for the SH-SY5Y cells of morphometric features including neurite length, branchpoint numbers, and soma area over the span of 18 days. Overall, we showed that in SH-SY5Y cells neurite length initially decreased followed by a dramatic increase of both neurite length and branching. In contrast, soma area for the SH-SY5Y cells initially increased and then stabilized; followed by a small decrease in size. By determining these morphological changes along various timepoints of SH-SY5Y cell development during the programmed cell differentiation process, we provide a set of baseline data for future mechanistic studies in human-derived neuronal cultures.

Identifiers

PMID38571511
PMCPMC10988288
OpenAlexW4394768185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.